Gyre Therapeutics, Inc. GYRE Operating margin

Operating margin at other companies

Madrigal Pharmaceuticals, Inc.MDGL

-25.1%-9.2pp

Theravance BiopharmaTBPH

-4%-1.9pp

Rigel PharmaceuticalsRIGL

41.6%+19.9pp

Zevra Therapeutics, Inc.ZVRA

-103.9%-43.0pp

LQD

Liquidia CorporationLQDA

-155%-68.1pp

BridgeBio PharmaBBIO

-69.8%-29.9pp

FAQ

What is Gyre Therapeutics, Inc.'s operating margin?

Gyre Therapeutics, Inc. (GYRE) reported operating margin of -14% in Q2 2026.

How has Gyre Therapeutics, Inc.'s operating margin changed year-over-year?

Gyre Therapeutics, Inc.'s operating margin decreased by 397.9% year-over-year, from 4.7% to -14%.

What is the long-term trend for Gyre Therapeutics, Inc.'s operating margin?

Over 4 years (2020 to 2025), Gyre Therapeutics, Inc.'s operating margin has grown at a -61.7% compound annual growth rate (CAGR), from -273.9% to 5.9%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.